StockData
SOPHiA GENETICS SA logo

SOPHiA GENETICS SA (SOPH) stock

SOPHNasdaqServices-Computer Processing & Data PreparationFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 3, 2026Score 4/30
$7.45+0.01 (+0.13%)

Close on Nov 17, 2026Market cap $510.22MP/E –Yield –

SOPHiA GENETICS r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2025 it was $34.22M, down 0.4% from the year before. The highest annual figure on record is $36.97M in fiscal 2023.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$34.22M-0.4%
FY2024Dec 31, 2024$34.37M-7.0%
FY2023Dec 31, 2023$36.97M+4.5%
FY2022Dec 31, 2022$35.37M+33.1%
FY2021Dec 31, 2021$26.58M+43.0%
FY2020Dec 31, 2020$18.59M+23.8%
FY2019Dec 31, 2019$15.02M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$8.73M-2.9%
Q2 FY2025Jun 30, 2025$8.49M–
Q2 FY2024Jun 30, 2024$7.96M–
Q2 FY2023Jun 30, 2023$8.89M–
Q2 FY2022Jun 30, 2022$8.99M–

More SOPHiA GENETICS figures

See a number that looks wrong?